Covid-era coercion and misinformation bred public distrust, but the vaccines did save countless lives.

With that in mind, let's consider two stocks that people in their 30s -- who are still a good distance away from retirement - ...

Scientists say HHS’ decision to defund mRNA vaccine research will leave the country less prepared for pandemics, and make it ...

The Nobel Prize-winning technology underpinning COVID-19 vaccines is also fueling a host of biotechs developing treatments ...

The average short interest in the S&P 500 Health Care Index Sector (XLV) dipped slightly in July to 1.95% from 1.96% in June.

Illinois researchers, including some working on vaccines for cancer and rare diseases, worry the federal government turning ...

Shares of the biotech Moderna were up on Wednesday, as the Trump administration’s shifting position on messenger RNA-based ...

The filly fits that bill and runs in the 6f handicap ( 5.05) with Oisin Murphy booked to ride for Imad Al Sagar for the second time since he replaced Doyle as the owner's retained rider. The champion ...

Mixed options sentiment in Moderna (MRNA), with shares down 9c near $26.80. Options volume relatively light with 20k contracts traded and calls ...

The Food and Drug Administration (FDA) is considering revoking the authorization of Pfizer’s COVID-19 vaccine for healthy ...

The U.S. government announced funding cuts to mRNA vaccine research. What is the impact on American healthcare and biotech?

Investors with a lot of money to spend have taken a bullish stance on Moderna MRNA. And retail traders should know. We noticed this today when the trades showed up on publicly available options ...